Tesco targets a 300 percent boost in sales compared with 2018 of plant-based meat, such as sausages and burgers, by 2025.
According to analyst firm Mintel, the UK market for products that emulate meat could be worth over $1.42 billion by 2024.
Between 2014 and 2019, UK sales of plant-based foods grew 40 percent from $751 million to an estimated $1.05 billion.
Tesco said that meat and dairy production is a key contributor to climate change and significantly impacts on environments such as the Amazon and Cerrado regions of Brazil.
Tesco also aims to introduce more plant-based varieties while also stocking meat.
The UK's largest retailer said it wanted to focus on making the products affordable and innovative.


Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 



